Judith Behrens
- Hematology top 1%
- Molecular Biology
- Oncology top 10%
- Genetics top 5%
- Physiology
- Co-authors
- Faith E. DaviesGareth J. MorganMark T. DraysonJ. A. ChildJanet DunnAlastair G. SmithBradley AugustsonGulnaz Begum
- Topics
- Multiple Myeloma Research and Treatments (8 papers)Lymphoma Diagnosis and Treatment (4 papers)Chronic Lymphocytic Leukemia Research (3 papers)
- Cited by
- HematologyGeneticsOncology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBritish Journal of Haematology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Judith Behrens
18 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 76
- Hematology 752
- Molecular Biology 468
- Oncology 366
- Genetics 219
- Physiology 175
Countries citing papers authored by Judith Behrens
This map shows the geographic impact of Judith Behrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Behrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Behrens more than expected).
Fields of papers citing papers by Judith Behrens
This network shows the impact of papers produced by Judith Behrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Behrens. The network helps show where Judith Behrens may publish in the future.
Co-authorship network of co-authors of Judith Behrens
This figure shows the co-authorship network connecting the top 25 collaborators of Judith Behrens. A scholar is included among the top collaborators of Judith Behrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Behrens. Judith Behrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 14 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 172 | |
| 6 | 223 | |
| 7 | 85 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 348 | |
| 11 | 139 | |
| 12 | 42 | |
| 13 | 40 | |
| 14 | 22 | |
| 15 | 6 | |
| 16 | 7 | |
| 17 | 24 | |
| 18 | The prevalence of seropositivity for human immunodeficiency virus in patients who have severe trauma. | 6 |
About Judith Behrens
Judith Behrens is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (752 citations), Genetics (219 citations) and Oncology (366 citations). Judith Behrens has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Faith E. Davies, Gareth J. Morgan, Mark T. Drayson, J. A. Child, Janet Dunn, Alastair G. Smith, Bradley Augustson, Gulnaz Begum, Chris Rogers and David Greenwood. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.